Soleno Therapeutics secures U.S. FDA approval for VYKAT XR to treat hyperphagia in Prader-Willi syndrome
The U.S. Food and Drug Administration (FDA) has approved Soleno Therapeutics’ VYKAT XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, for the treatment of hyperphagia in adults and children 4 years of age and older with …